NO20021306L - Formuleringer for parenteral bruk av estramustinfosfat med forbedrede formakologiske egenskaper - Google Patents

Formuleringer for parenteral bruk av estramustinfosfat med forbedrede formakologiske egenskaper

Info

Publication number
NO20021306L
NO20021306L NO20021306A NO20021306A NO20021306L NO 20021306 L NO20021306 L NO 20021306L NO 20021306 A NO20021306 A NO 20021306A NO 20021306 A NO20021306 A NO 20021306A NO 20021306 L NO20021306 L NO 20021306L
Authority
NO
Norway
Prior art keywords
formacological
formulations
properties
improved
parenteral use
Prior art date
Application number
NO20021306A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021306D0 (no
Inventor
Lorena Muggetti
Paolo Colombo
Alessandro Martini
Giovanni Buzzi
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of NO20021306D0 publication Critical patent/NO20021306D0/no
Publication of NO20021306L publication Critical patent/NO20021306L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20021306A 1999-09-16 2002-03-15 Formuleringer for parenteral bruk av estramustinfosfat med forbedrede formakologiske egenskaper NO20021306L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9921954.5A GB9921954D0 (en) 1999-09-16 1999-09-16 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties
PCT/EP2000/007679 WO2001019338A1 (en) 1999-09-16 2000-08-03 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties

Publications (2)

Publication Number Publication Date
NO20021306D0 NO20021306D0 (no) 2002-03-15
NO20021306L true NO20021306L (no) 2002-04-24

Family

ID=10861066

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021306A NO20021306L (no) 1999-09-16 2002-03-15 Formuleringer for parenteral bruk av estramustinfosfat med forbedrede formakologiske egenskaper

Country Status (20)

Country Link
EP (1) EP1212040A1 (ko)
JP (1) JP2003509355A (ko)
KR (1) KR20020059405A (ko)
CN (1) CN1177583C (ko)
AU (1) AU777763B2 (ko)
BR (1) BR0014063A (ko)
CA (1) CA2385063A1 (ko)
CZ (1) CZ2002943A3 (ko)
EA (1) EA005308B1 (ko)
GB (1) GB9921954D0 (ko)
HK (1) HK1047227A1 (ko)
HU (1) HUP0202621A2 (ko)
IL (1) IL148409A0 (ko)
MX (1) MXPA02002859A (ko)
NO (1) NO20021306L (ko)
NZ (1) NZ517631A (ko)
PL (1) PL353954A1 (ko)
SK (1) SK3452002A3 (ko)
WO (1) WO2001019338A1 (ko)
ZA (1) ZA200201743B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658913B2 (en) 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof
WO2012037704A1 (en) 2010-09-21 2012-03-29 Telefonaktiebolaget L M Ericsson (Publ) Air-interface timing synchronization sharing
WO2019094819A2 (en) * 2017-11-09 2019-05-16 Abon Pharmaceuticals, Llc Intravenous delivery systems for chemotherapy drugs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59108800A (ja) * 1982-12-13 1984-06-23 Japan Atom Energy Res Inst 誘導ミサイル作用および制癌剤の徐放性機能をもつ微粒子
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5602112A (en) * 1992-06-19 1997-02-11 Supergen, Inc. Pharmaceutical formulation
GB9419153D0 (en) * 1994-09-22 1994-11-09 Erba Carlo Spa Estramustine formulations with improved pharmaceutical properties
US20020039594A1 (en) * 1997-05-13 2002-04-04 Evan C. Unger Solid porous matrices and methods of making and using the same

Also Published As

Publication number Publication date
CZ2002943A3 (cs) 2002-08-14
HK1047227A1 (zh) 2003-02-14
KR20020059405A (ko) 2002-07-12
HUP0202621A2 (hu) 2002-12-28
EP1212040A1 (en) 2002-06-12
MXPA02002859A (es) 2003-07-21
CN1374858A (zh) 2002-10-16
AU777763B2 (en) 2004-10-28
WO2001019338A1 (en) 2001-03-22
AU6836300A (en) 2001-04-17
NZ517631A (en) 2004-01-30
CA2385063A1 (en) 2001-03-22
EA005308B1 (ru) 2004-12-30
JP2003509355A (ja) 2003-03-11
SK3452002A3 (en) 2002-08-06
ZA200201743B (en) 2003-05-28
PL353954A1 (en) 2003-12-15
EA200200369A1 (ru) 2002-08-29
CN1177583C (zh) 2004-12-01
BR0014063A (pt) 2004-06-29
GB9921954D0 (en) 1999-11-17
IL148409A0 (en) 2002-09-12
NO20021306D0 (no) 2002-03-15

Similar Documents

Publication Publication Date Title
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
HUP0202477A3 (en) Use of phthalazine derivatives
PL352296A1 (en) Crystalline derivatives of 1-methylocarbapeneme
HK1051142A1 (en) Formulation of substituted benzimidazoles
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO20021306L (no) Formuleringer for parenteral bruk av estramustinfosfat med forbedrede formakologiske egenskaper
IL149534A0 (en) Preparation of 3-substituted-4-arylquinolin-2-one derivatives
NO20020059D0 (no) Fremgangsmåte for fremstilling av dibenzotiazepinderivater
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
GB9921958D0 (en) Formulations for parenteral use of estramustine phosphate and sulfoalkylether-cyclodextrins
NO20020631D0 (no) Formuleringer for parenteral bruk av estramustinfosfat og albumin
MA26838A1 (fr) Derives d'hygromycine
ITMI992048A0 (it) Procedimento stereoselettivo per la preparazione di endo-3-amminoazabi cicloalcani
NO20014383D0 (no) Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20016030L (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
NO20022244D0 (no) Behandling av SLE med dehydroepiandrosteron
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20013044L (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20021234D0 (no) Anvendelse av tienopyrimidiner
GB9930554D0 (en) The manufacture of implements
NO20013453L (no) Fremgangsmate for fremstilling av salter av cyanobenzylaminer
IL146505A0 (en) Methods for the preparation of tetrahydroisoquinolinephenol derivatives
NO20014451D0 (no) Fremgangsmåte for fremstilling av tiazolidinderivater
IL132329A0 (en) Inhibition of dyslexia

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application